Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. PENTASA PROLONGED RELEASE GRANULES 2G/SACHET [SIN14456P]

PENTASA PROLONGED RELEASE GRANULES 2G/SACHET [SIN14456P]

Active ingredients: PENTASA PROLONGED RELEASE GRANULES 2G/SACHET

Last updated 26 October 2025

Product Info

PENTASA PROLONGED RELEASE GRANULES 2G/SACHET

[SIN14456P]

Product information

Active Ingredient and Strength

MESALAZINE - 2,000 MG

Dosage Form

GRANULE, DELAYED RELEASE

Manufacturer and Country

FERRING INTERNATIONAL CENTER SA - SWITZERLAND

Registration Number

SIN14456P

Licence Holder

FERRING PHARMACEUTICALS PRIVATE LIMITED

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

A07EC02

THERAPEUTIC INDICATIONS
Treatment of mild to moderate ulcerative colitis.

POSOLOGY AND METHOD OF ADMINISTRATION
Posology:
Ulcerative colitis
Treatment of active disease:
Adults: Individual dosage, up to 4 g given once daily or in divided doses.

Paediatric population:
There is only limited documentation for an effect in children (age 6–18 years).

Method of administration:
PENTASA® granules must not be chewed. The contents of the sachet should be emptied onto the tongue and washed down with some water or orange juice. Alternatively the entire content of the sachet can be taken with yogurt and consumed immediately.

CONTRAINDICATIONS
Hypersensitivity to mesalazine, any of the excipients, or salicylates.
Severe liver or renal impairment.